Stocktoria
Viskase Holdings, Inc. ENZN
OTC · OOTC · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1984-02-16
Viskase Holdings, Inc. statistics & valuation
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
P / E vs its own history
Viskase Holdings, Inc. trades at about 41.6× earnings — above its 10-year norm (10-year range 1×–2.4×, median 2×).
1×
2.4×
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | -5103.8% | — | -3969.2% | -66.9% | -2509.6% | -470.0% | — | — | — |
| Net margin | — | 2992.3% | — | -715.4% | -66.9% | -2521.2% | -472.9% | 84.5% | 65.0% | -13.4% |
| Return on assets | -0.8% | 1.6% | 2.9% | -0.4% | -1.0% | -2.7% | -15.1% | 37.7% | 57.2% | -10.0% |
| Return on equity | -2.3% | 0.5% | -39.2% | -5.5% | -9.6% | -17.8% | -16.2% | 39.0% | 59.5% | -10.9% |
| Debt / equity | 0.97× | — | — | — | — | — | — | — | — | — |
| Current ratio | 0.97 | 28.10 | 27.62 | 27.89 | 118.50 | 117.07 | 14.17 | 28.12 | 20.58 | 8.41 |
Source: SEC EDGAR filings · CIK 0000727510 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.